Home Sign In About Curriculum Ask the Experts     New!   Additional Information Target Audience Programme Goal Learning Objectives Certificate Requirements Faculty Roster Disclosures Technical Requirements
The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from
Novartis Oncology

Created in consultation with
Projects In Knowledge®, developers of certificate programs in medicine.

Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.

Course materials have been developed for use outside of the United States.

grid
banner
View information by clicking on column heads and/or using drop down boxes below.

      Show Coming Soon


CURRENT CURRICULA
  Curriculum 4
  Curriculum 3
  Curriculum 2
  Curriculum 1
 
Curriculum 4 Curriculum 3 Curriculum 2 Curriculum 1
  TITLE FACULTY TOPIC DISEASE STATE
3-IC06.01  Iron Chelator Basics: Emerging Data —Webcast (Dec 2009) 1919 Pietrangelo
Piperno
Iron Metabolism/Regulation
Epidemiology & Pathology
Iron Toxicity and Clinical Sequelae
Iron Chelation Therapy
Treatment and Monitoring of Iron Overload
Iron Deficiency Anaemia/Rare Anaemia
Iron Metabolism/Regulation

3-IC00.04  Iron Overload Case Library II, Case 4: Noncompliance with Iron Chelation Therapy in an Adolescent with Thalassaemia Major —Webcast (Nov 2009) 1928.04 Inati
Diagnosis of Iron Overload
Iron Chelation Therapy
Treatment and Monitoring of Iron Overload
Managing Side Effects and Non-Compliance
Case Study
Thalassaemia

3-IC00.03  Iron Overload Case Library II, Case 3: The Role of Iron Chelation in High-Risk Myelodysplastic Syndromes Before Allogeneic Haematopoietic Stem Cell Transplant —Webcast (Nov 2009) 1928.03 Giagounidis
Iron Toxicity and Clinical Sequelae
Iron Chelation Therapy
Treatment and Monitoring of Iron Overload
Case Study
Myelodysplastic Syndromes

3-IC03.01  Update on Microcytic Anaemias —Webcast (Oct 2009) 1903 Beris
Iolascon
Iron Metabolism/Regulation
Epidemiology & Pathology
Iron Deficiency Anaemia/Rare Anaemia
Iron Metabolism/Regulation

3-IC00.02  Iron Overload Case Library II, Case 2: Adjusting Chelator Dose in Response to Adverse Events in a Patient with Sickle Cell Disease —Webcast (Oct 2009) 1928.02 de Montalembert
Iron Chelation Therapy
Treatment and Monitoring of Iron Overload
Managing Side Effects and Non-Compliance
Case Study
Sickle Cell Disease

3-IC05.01  Update on Imaging: Detection of Iron in Liver and Heart —Webcast (Oct 2009) 1918 St. Pierre
Iron Toxicity and Clinical Sequelae
Diagnosis of Iron Overload
Iron Deficiency Anaemia/Rare Anaemia

3-IC04.01  Update on Iron Toxicity in Myelodysplastic Syndromes —Webcast (Sep 2009) 1917 Giagounidis
Roghi
Iron Metabolism/Regulation
Epidemiology & Pathology
Iron Toxicity and Clinical Sequelae
Iron Chelation Therapy
Myelodysplastic Syndromes
Iron Metabolism/Regulation

3-IC00.01  Iron Overload Case Library II, Case 1: Managing Iron Overload in a Patient with Transfusion-Independent Thalassaemia Intermedia —Webcast (Sep 2009) 1928.01 Taher
Diagnosis of Iron Overload
Iron Chelation Therapy
Treatment and Monitoring of Iron Overload
Managing Side Effects and Non-Compliance
Case Study
Thalassaemia

3-IC01.01  Update on Hepcidin Regulation in Different Disorders —Webcast (Jul 2009) 1916 Brissot
Iron Metabolism/Regulation
Epidemiology & Pathology
Hereditary Haemochromatosis
Iron Metabolism/Regulation

3-IC07.01  Clinical Trial Updates: What Do the Data Say About the Management of Iron Overload? —Video (Jul 2009) 1920 Cappellini
Giagounidis
Taher
Epidemiology & Pathology
Iron Toxicity and Clinical Sequelae
Diagnosis of Iron Overload
Iron Chelation Therapy
Treatment and Monitoring of Iron Overload
Myelodysplastic Syndromes
Thalassaemia
Iron Metabolism/Regulation

3-IC02.01  Overview of Myelodysplastic Syndromes with Focus on Iron —Webcast (May 2009) 1902 Gattermann
Iron Metabolism/Regulation
Epidemiology & Pathology
Iron Toxicity and Clinical Sequelae
Iron Chelation Therapy
Treatment and Monitoring of Iron Overload
Myelodysplastic Syndromes
Iron Metabolism/Regulation

3-IC08.01  Series of 10 Reports from the 50th American Society of Hematology (ASH) Annual Meeting and Exposition in San Francisco, California 2008 —Meeting Coverage (Jan 2009) 1888 Other
Iron Toxicity and Clinical Sequelae
Iron Chelation Therapy
Treatment and Monitoring of Iron Overload
Managing Side Effects and Non-Compliance
Myelodysplastic Syndromes
Thalassaemia
Iron Deficiency Anaemia/Rare Anaemia

ESH-Centre Hayem, Hôspital Saint-Louis, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France - Contacts
All Rights Reserved - Copyright ESH 2010